Perrigo says FDA clears Allegan facility
A year after receiving a warning from regulators, over-the-counter drug maker Perrigo Co. said Tuesday that a manufacturing facility in Michigan now meets regulatory standards.
Perrigo said any export or generic drug applications from the facility are now eligible for review by the Food and Drug Administration. The FDA sent Perrigo a warning letter about the facility in April 2010, saying the company had been receiving complaints for years about tablet contamination, that its quality control unit did not follow written procedures, and that Perrigo was not taking steps to prevent the problems.
Shares of Perrigo rose 19 cents to $84.50 in afternoon trading.